
Memory & Thinking Improve in Crenezumab Dementia Trial
An Alzheimer’s vaccination called crenezumab just finished 2 trials. The drug showed clear, positive cognitive improvements in people with mild Alzheimer’s. Learn more about the

An Alzheimer’s vaccination called crenezumab just finished 2 trials. The drug showed clear, positive cognitive improvements in people with mild Alzheimer’s. Learn more about the

PseudoBulbar Affect (PBA) is a distressing neurologic condition characterized by sudden and uncontrolled outbursts of laughing and/or crying. Learn how Nuedexta, a new drug in

VIDEO & ARTICLE: Why were people with rheumatoid arthritis getting less Alzheimer’s? Find out how the answer to this question has triggered an anti-Alzheimer’s trial

RESEARCH VIDEO – Alzheimer’s International Conference: See NIH-sponsored research exploring intranasal insulin as a potentially strong treatment for dementia.

The Alzheimer’s drugs on the market today help compensate for the problems caused by Alzheimer’s. However, they do not stop the disease or change its

VIDEO The A4 Study uses the drug solanezumab in one of the most ambitious attempts yet to thwart Alzheimer’s. The major clinical trial got underway

Research has shown that the Parkinson’s drug, rasagiline, could be a viable therapeutic option for people with Alzheimer’s disease. Learn about the new effort to

VIDEO + ARTICLE CERE-110 is a big step forward for Alzheimer’s clinical trials. It induces brain cells to make their own nerve-growth-factor, so they can

VIDEO & ARTICLE: See how doctors implant a deep-brain-stimulation device in “The Advance Study”. Learn how its electrodes stimulate a part of the brain called

VIDEO+ARTICLE Cognoptix announced strong results in a clinical trial of its SAPPHIRE II eye test. It successfully identified Alzheimer’s via the human eye’s beta-amyloid signature.

Posterior Cortical Atrophy, or PCA, is a specific form of Alzheimer’s that affects the back of the brain.
Author Terry Pratchett was diagnosed with it.

New evidence suggests genetics—not geography—may explain why Leqembi causes fewer ARIA brain side effects in parts of Asia, and what that means for families everywhere.

NEW YEAR’S VIDEO & ARTICLE: New Year’s Eve can still be a fun, enjoyable experience for loved ones with dementia. It’s a perfect moment to reflect on past moments that warmed the soul.
Learn how reminiscing makes for a great activity.

Meet Marley, a THERAPAWS therapy dog, helping the elderly that suffer from dementia. See pet therapy at work.

Alzheimer’s is the most common type of dementia, but it is just one cause. In this short Q & A, watch Stanford Neurologist Dr. Kerchner explain the importance of getting an accurate diagnosis.

The “glymphatic system” removes brain waste. It may be a powerful new target to treat Alzheimer’s. Learn why scientists believe Alzheimer’s may arise when the system is not doing its cleaning properly.

Plaques are the best-known Alzheimer’s culprit. Cambridge scientists have figured out the 7 steps to forming these plaques. Find out how targeting the formation of these “oligomers” may hold the key to a cure.
No spam, only news and updates.


